Sign In
Buy APLS
$41.03
+0 (+0%)
At Close: Jun 03, 2026
Amazon Unleashes Dozens of Alexa Developer Improvements - Thurrott.com
05:33pm, Wednesday, 22'nd Jul 2020
At its Alexa Live 2020 virtual event today, Amazon has announced dozens of new features for developers targeting the Alexa voice assistant.
Amazon launches Alexa Conversations in beta, lets developers deep-link skills to mobile apps
04:00pm, Wednesday, 22'nd Jul 2020
During Alexa Live, a virtual event for Alexa vendors and developer partners, Amazon unveiled tools designed to enable new Alexa voice experiences.
Sustenance vs Succour: With political will, PDS can be reformed
06:45am, Monday, 20'th Jul 2020
Weekly DBT through biometric-enabled electronic debit cards can be considered
Predicting Taxi Destinations with SAP HANA
03:27pm, Thursday, 16'th Jul 2020
Showing the advantages of multi-model data processing based on a real-life example
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Upgraded by BidaskClub
01:54pm, Thursday, 16'th Jul 2020
Apellis Pharmaceuticals (NASDAQ:APLS) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a report released on Tuesday, BidAskClub reports. A number of other analysts also rec
Did Hedge Funds Make The Right Call On Apellis Pharmaceuticals, Inc. (APLS) ?
02:31pm, Monday, 13'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Aktivis lingkungan sarankan pengelolaan berkelanjutan APL Batang Toru
01:22pm, Monday, 13'th Jul 2020
Aktivis lingkungan Emmy Hafild menyarankan semua pemangku kepentingan melakukan pengelolaan berkelanjutan di Area Penggunaan Lain (APL) ekosistem Batang Toru, ...
Parametric Portfolio Associates LLC Increases Stock Position in Apellis Pharmaceuticals Inc (NASDAQ:APLS)
07:56am, Saturday, 11'th Jul 2020
Parametric Portfolio Associates LLC lifted its holdings in shares of Apellis Pharmaceuticals Inc (NASDAQ:APLS) by 4.3% in the first quarter, according to the company in its most recent filing with the
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:05pm, Tuesday, 07'th Jul 2020
Apellis Pharmaceuticals, Inc. (APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company approved the grant of equity awards to three new employees w
Apellis Pharmaceuticals Inc., (APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that it completed enrollment in the Phase 3 DERBY and OAKS studies investiga
CMA CGM Reorganizes its Transpacific Trade Network
10:02pm, Monday, 06'th Jul 2020
French shipping group CMA CGM says it is simplifying its transpacific trade network by removing APL from the trade and naming CMA CGM as the group’s exclusive commercial carrier. APL will focus on �
PolyPid Phase 3 And Other News: The Good, Bad And Ugly Of Biopharma
03:31am, Sunday, 05'th Jul 2020
Polypid starts phase 3 trial in prevention of post-abdominal surgery incisional infection. Apellis completes Phase 3 enrolment for Pegcetacoplan. Regeneron dips
Invesco Ltd. Acquires Shares of 357,676 Apellis Pharmaceuticals Inc (NASDAQ:APLS)
07:10am, Saturday, 04'th Jul 2020
Invesco Ltd. acquired a new position in Apellis Pharmaceuticals Inc (NASDAQ:APLS) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
Les associations s'inquiètent du sort des SDF à la fin de l'état d'urgence sanitaire
04:13pm, Thursday, 02'nd Jul 2020
Le 10 juillet marquera la fin de l'état d'urgence sanitaire en France. Le gouvernement a promis de « prévenir toute remise à la rue sans solution ». Les associations d'aide aux plus démunis o
PRINCE study enrolled 53 patients. WALTHAM, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS), a global biopharmaceutical company pioneering targeted C3 therapies, toda
